H. A. van der Korput

发表

Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis.

T. H. van der Kwast, A. Berns, P. V. van Duijn, 2005, Cancer research.

A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans.

L. Chung, R. Sikes, J. Trapman, 1997, Molecular endocrinology.

A small chimeric promoter for high prostate‐specific transgene expression from adenoviral vectors

R. Kraaij, J. Trapman, C. D. de Ridder, 2007, The Prostate.

Characterization of the human androgen receptor transcription unit.

J. Trapman, J. Grootegoed, A. Brinkmann, 1991, The Journal of biological chemistry.

An Sp1 binding site is essential for basal activity of the human prostate-specific transglutaminase gene (TGM4) promoter.

J. Romijn, H. Dubbink, K. Cleutjens, 1999, Gene.

An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.

J. Trapman, K. Cleutjens, H. V. van Rooij, 1997, Molecular endocrinology.

Two Androgen Response Regions Cooperate in Steroid Hormone Regulated Activity of the Prostate-specific Antigen Promoter (*)

J. Trapman, A. Brinkmann, K. Cleutjens, 1996, The Journal of Biological Chemistry.

Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.

T. H. van der Kwast, G. Jenster, H. van Dekken, 2008, Cancer research.

Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer.

G. Jenster, N. Dits, J. Trapman, 2008, Cancer research.

A mononucleotide repeat in PRRT2 is an important, frequent target of mismatch repair deficiency in cancer

G. Jenster, W. Dinjens, J. Trapman, 2016, Oncotarget.

Overexpression of Full-Length ETV1 Transcripts in Clinical Prostate Cancer Due to Gene Translocation

A. de Klein, J. Trapman, C. D. de Ridder, 2011, PloS one.

Identification of Two Transcription Activation Units in the N-terminal Domain of the Human Androgen Receptor (*)

G. Jenster, J. Trapman, A. Brinkmann, 1995, The Journal of Biological Chemistry.

A 36-gene signature predicts clinical progression in a subgroup of ERG-positive prostate cancers.

G. Jenster, J. Trapman, J. Boormans, 2013, European urology.

PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum.

A. Berns, S. Brandner, J. Trapman, 2002, Development.

A bioinformatics-based functional analysis shows that the specifically androgen-regulated gene SARG contains an active direct repeat androgen response element in the first intron.

A. Houtsmuller, A. Z. D. Ziel-van der Made, J. Trapman, 2004, Journal of molecular endocrinology.

Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma

A. Hofman, A. Uitterlinden, W. Dinjens, 2015, Journal of carcinogenesis.

Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization.

T. H. van der Kwast, G. Jenster, J. Trapman, 1991, Molecular endocrinology.

Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sites.

G. Jenster, J. Trapman, A. Brinkmann, 1994, Biochemistry.

Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor.

Chandra S Verma, Hendrikus J Dubbink, Jan Trapman, 2004, Molecular endocrinology.

Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.

T. H. van der Kwast, G. Jenster, H. van Dekken, 2008, Cancer research.